Nature Communications (May 2019)

Loss of TET2 and TET3 in regulatory T cells unleashes effector function

  • Xiaojing Yue,
  • Chan-Wang J. Lio,
  • Daniela Samaniego-Castruita,
  • Xiang Li,
  • Anjana Rao

DOI
https://doi.org/10.1038/s41467-019-09541-y
Journal volume & issue
Vol. 10, no. 1
pp. 1 – 14

Abstract

Read online

Loss of TET proteins in immune cell populations is known to result in immunopathology. Here the authors show that deficiency of Tet2 and Tet3 proteins, specifically in the CD4+ FoxP3+ Treg lineage, results in a dominant pathology in which ex-Treg cells and bystander T cells gain aberrant effector function.